Microstructural but not macrostructural cortical degeneration occurs in Parkinson's disease with mild cognitive

Xueqin Bai1, Tao Guo1, Jingwen Chen1

  • 1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 310009, Hangzhou, China.

NPJ Parkinson'S Disease
|November 9, 2022
PubMed

Insights

Parkinson's disease with mild cognitive impairment (PD-MCI) shows early cortical microstructural changes, specifically reduced neurite orientation dispersion index (ODI), which correlate with cognitive function. These microstructural alterations appear before macrostructural changes in PD-MCI patients.

Area of Science:

  • Neuroscience
  • Neurology
  • Radiology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder.
  • Mild cognitive impairment (MCI) is common in PD patients, impacting daily function.
  • Understanding early degenerative patterns in PD-MCI is crucial for timely intervention.

Purpose of the Study:

  • To investigate cortical microstructural and macrostructural changes in Parkinson's disease patients with mild cognitive impairment (PD-MCI).
  • To compare these changes between PD patients with normal cognition (PD-NC), PD-MCI, and healthy controls (HC).
  • To explore the relationship between microstructural alterations and cognitive performance in PD.

Main Methods:

  • Included 38 PD-NC, 38 PD-MCI, and 32 HC participants.
  • Assessed cortical microstructural alterations using Neurite Orientation Dispersion and Density Imaging (NODDI).
  • Evaluated cortical thickness via T1-weighted imaging using FreeSurfer software.

Main Results:

  • PD-NC and PD-MCI groups showed reduced orientation dispersion index (ODI) in various cortical regions compared to HC.
  • PD-MCI patients exhibited more widespread ODI reductions and decreased neurite density index (NDI) in frontal and cingulate areas compared to PD-NC.
  • Reduced ODI in PD-MCI correlated significantly with Montreal Cognitive Assessment scores and memory performance.
  • No significant differences in cortical thickness were observed between groups.

Conclusions:

  • Cortical microstructural alterations, particularly in ODI, are present in PD-MCI and may precede macrostructural changes.
  • These microstructural changes are associated with cognitive deficits in PD.
  • Findings highlight the potential of microstructural imaging for detecting early cognitive impairment in Parkinson's disease.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
671
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
625
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
350
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
155
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
245